TR200301671A2 - Sitalopram'ın yeni üretim formülasyonu. - Google Patents

Sitalopram'ın yeni üretim formülasyonu.

Info

Publication number
TR200301671A2
TR200301671A2 TR2003/01671A TR200301671A TR200301671A2 TR 200301671 A2 TR200301671 A2 TR 200301671A2 TR 2003/01671 A TR2003/01671 A TR 2003/01671A TR 200301671 A TR200301671 A TR 200301671A TR 200301671 A2 TR200301671 A2 TR 200301671A2
Authority
TR
Turkey
Prior art keywords
sitalopram
new production
production formulation
formulation
present
Prior art date
Application number
TR2003/01671A
Other languages
English (en)
Inventor
Seyed Farshi Farhad
Original Assignee
Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2003/01671A priority Critical patent/TR200301671A2/tr
Publication of TR200301671A2 publication Critical patent/TR200301671A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut bulus; depresyon tedavisinde kullanilan 1-[3-(dimethylamino)-propyl]-1- (4-fluorophenyl)-1, 3-dizohydro-5-izobenzofurancarbonitrile formülüne sahip sitalopramin formülasyonunda ortaya çikan sorunlarin giderilmesi, in vitro dissolüsyon profilinin iyilestirilmesi amaciyla gelistirilmistir.
TR2003/01671A 2003-10-03 2003-10-03 Sitalopram'ın yeni üretim formülasyonu. TR200301671A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2003/01671A TR200301671A2 (tr) 2003-10-03 2003-10-03 Sitalopram'ın yeni üretim formülasyonu.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2003/01671A TR200301671A2 (tr) 2003-10-03 2003-10-03 Sitalopram'ın yeni üretim formülasyonu.

Publications (1)

Publication Number Publication Date
TR200301671A2 true TR200301671A2 (tr) 2005-05-23

Family

ID=34651628

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/01671A TR200301671A2 (tr) 2003-10-03 2003-10-03 Sitalopram'ın yeni üretim formülasyonu.

Country Status (1)

Country Link
TR (1) TR200301671A2 (tr)

Similar Documents

Publication Publication Date Title
DK1689721T3 (da) Aminopyrazolderivater som GSK-3-ihibitorer
NO20055516L (no) Kannabinoidreceptorligander og anvendelser derav
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
JO2282B1 (en) Oxazole derivatives
NO20060230L (no) Nye aminobenzofenonforbindelser
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
UY27368A1 (es) Nuevos compuestos
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
ATE384058T1 (de) Thiazolderivate
SE0403006D0 (sv) New compounds
SE0302760D0 (sv) New compounds
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
EA200600223A1 (ru) Замещённый 2-аминотетралины для лечения депрессии
BRPI0410649A (pt) benzo(b) tiofeno 3-arilóxi e 3-heteroarilóxi substituìdos como agentes terapêuticos com atividade pi3k
SE0201544D0 (sv) Novel compounds and thier use
DE60045508D1 (de) Dalda-analoge und ihre verwendung
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
ATE409480T1 (de) Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren
ECSP088829A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1)
ATE397601T1 (de) Pyridin-4-yl-ethynylimidazole und -pyrazole als antagonisten des mglu5-rezeptors
SE0104331D0 (sv) Novel compounds
ATE403428T1 (de) Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren
ATE365735T1 (de) Cycloalkylsulfanyl-substituierte benzo böthiophene als therapeutische mittel
NO20055741D0 (no) Nye kjemiske forbindelser
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли